OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway
Hualong Wang, Shisheng Shan, Hongbo Wang, et al.
Anti-Cancer Drugs (2021) Vol. 33, Iss. 1, pp. e700-e710
Closed Access | Times Cited: 18
Hualong Wang, Shisheng Shan, Hongbo Wang, et al.
Anti-Cancer Drugs (2021) Vol. 33, Iss. 1, pp. e700-e710
Closed Access | Times Cited: 18
Showing 18 citing articles:
Circular RNAs in breast cancer diagnosis, treatment and prognosis
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
Exploring extracellular RNA as drivers of chemotherapy resistance in cancer
Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 2
Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 2
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
Lei Zhang, Biwei Ye, Zhuo Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 982-997
Open Access | Times Cited: 56
Lei Zhang, Biwei Ye, Zhuo Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 982-997
Open Access | Times Cited: 56
The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
In silico Analysis and Comprehensive Review of Circular-RNA Regulatory Roles in Breast Diseases; a Step-Toward non-coding RNA Precision
Nadia Μ. Hamdy, Mona G. El-Sisi, Sherine M. Ibrahim, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155651-155651
Closed Access | Times Cited: 6
Nadia Μ. Hamdy, Mona G. El-Sisi, Sherine M. Ibrahim, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155651-155651
Closed Access | Times Cited: 6
Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
Lixin Li, Y. Hao, Lei Dong, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Lixin Li, Y. Hao, Lei Dong, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Guangtao Shi, Hongbo Li, Ying Chen, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 10, pp. 808-819
Open Access | Times Cited: 3
EIF4A3-induced circBRWD3 promotes tumorigenesis of breast cancer through miR-142-3p_miR-142-5p/RAC1/PAK1 signaling
Xianguo Meng, Wei Li, Meng Ziqi, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Xianguo Meng, Wei Li, Meng Ziqi, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
circRNAs in drug resistance of breast cancer
Sema Mısır, SERAP OZER YAMAN, Nina Petrović, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2022) Vol. 30, Iss. 4, pp. 157-172
Open Access | Times Cited: 11
Sema Mısır, SERAP OZER YAMAN, Nina Petrović, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2022) Vol. 30, Iss. 4, pp. 157-172
Open Access | Times Cited: 11
Circular RNAs in the chemoresistance of triple‐negative breast cancer: A systematic review
Hongmei Wang, Xuefeng Shan, Yang Peng, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 805-814
Closed Access | Times Cited: 4
Hongmei Wang, Xuefeng Shan, Yang Peng, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 805-814
Closed Access | Times Cited: 4
Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer
Nafiseh Tashakori, M. V. Mikhailova, Zainab Abbas Mohammedali, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155569-155569
Closed Access | Times Cited: 1
Nafiseh Tashakori, M. V. Mikhailova, Zainab Abbas Mohammedali, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155569-155569
Closed Access | Times Cited: 1
The role of circRNAs in resistance to doxorubicin
Mahla Sanati, Soudeh Ghafouri‐Fard
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Mahla Sanati, Soudeh Ghafouri‐Fard
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer
Xiaoqiang Guo, Yuming Hua
Neoplasma (2022) Vol. 69, Iss. 05, pp. 1019-1028
Open Access | Times Cited: 4
Xiaoqiang Guo, Yuming Hua
Neoplasma (2022) Vol. 69, Iss. 05, pp. 1019-1028
Open Access | Times Cited: 4
StemRegenin-1 Reverses Drug Resistance of MCF-7/ADR Cells via AhR/ABC Transports and AhR/UGTs Pathways
Yang Zhang, Yuchen Ma, Jue Song, et al.
Current Proteomics (2024) Vol. 21, Iss. 2, pp. 113-128
Closed Access
Yang Zhang, Yuchen Ma, Jue Song, et al.
Current Proteomics (2024) Vol. 21, Iss. 2, pp. 113-128
Closed Access
CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5
Luni Guo, Min Wang, Wenhui Zhao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111341-111341
Closed Access
Luni Guo, Min Wang, Wenhui Zhao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111341-111341
Closed Access
Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
Yiwei Liu, Yuhan Zou, Yangli Ye, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access
Yiwei Liu, Yuhan Zou, Yangli Ye, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access
Expression of CircATXN7 in esophageal cancer tissues and its effect on cell proliferation and invasion
Delin Liu, Hui Jia, Jianwei Lu, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 3, pp. 912-922
Open Access | Times Cited: 1
Delin Liu, Hui Jia, Jianwei Lu, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 3, pp. 912-922
Open Access | Times Cited: 1
